Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 17/8/2017
SIETES contiene 91969 citas

 
 
 1 a 20 de 261 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
Nair NP, Chalmers L, Bereznicki BJ, Curtain C, Peterson GM, Connolly M, Bereznicki LR. Adverse drug reaction-related hospitalizations in elderly Australians: a prospective cross-sectional study in two Tasmanian hospitals. Drug Saf 2017;40:597-606. [Ref.ID 101969]
4. Cita con resumen
O'Brien E. Salt—too much or too little?. Lancet 2016;388:439-40. [Ref.ID 100512]
5. Cita con resumen
Yaffe K, Falvey CM, Hamilton N, Harris TB, Simonsick EB, Strotmeyer ES, Shorr RI, Metti A, Schwartz AV, Health ABC Study. Association between hypoglycemia and dementia in a biracial cohort of older adults with diabetes mellitus. JAMA Intern Med 2013;173:1300-6. [Ref.ID 95868]
6. Cita con resumen
7. Cita con resumen
Mills EJ, Ioannidis JPA, Thorlund K, Schünemann HJ, Puhan MA, Guyatt GH. How to use an article reporting a multiple treatment comparison meta-analysis. JAMA 2012;308:1246-53. [Ref.ID 93801]
8. Cita con resumen
Anónimo. The truth about good medical research. Lancet 2012;379:2118. [Ref.ID 93193]
9. Cita con resumen
Avorn J. Learning about the safety drugs - A half-century of evolution. N Engl J Med 2011;365:2151-3. [Ref.ID 91927]
10.Enlace a cita original
Sabaté M, Ibáñez L, Pérez E, Vidal X, Buti M, Xiol X, Mas A, Guarner C, Forné M, Solà R, Castellote J, Rigau J, Laporte JR. Paracetamol in therapeutic dosages and acute liver injury: causality assessment in a prospective case series. BMC Gastroenterology 2011;11:80. [Ref.ID 91075]
11. Cita con resumen
Canonico M, Fournier A, Carcaillon L, Olié V, Plu-Bureau G, Oger E, Mesrine S, Boutron-Ruault M-C, Clavel-Chapelon F, Scarabin PY. Postmenopausal hormone therapy and risk of idiopathic venous thromboembolism. Results from the E3N Cohort Study. Artherioscler Thromb Vasc Biol 2010;30:340-5. [Ref.ID 88483]
12. Cita con resumen
Anónimo. Risque de cancers chez des patients diabétiques traités par insuline glargine?. Prescrire 2010;30:268-70. [Ref.ID 88326]
13. Cita con resumen
Anónimo. Insulin glargine (Lantus) and cancer risk. Med Lett Drugs Ther 2009;51:67-8. [Ref.ID 86494]
14. Cita con resumen
von Elm E, Moher D, Little J, on behalf of the STREGA collaboration. Reporting genetic association studies: the STREGA statement. Lancet 2009;374:98-100. [Ref.ID 86325]
15.Tiene citas relacionadas Cita con resumen
Avorn J, Schneewiss S. Immunosuppressants, mortality, and risk of cancer. BMJ 2009;339:59-60. [Ref.ID 86223]
16.Enlace a cita originalTiene citas relacionadas Cita con resumen
Smith U, Gale EAM. Does diabetes therapy influence the risk of cancer?. Diabetologia 2009;52:1699-708. [Ref.ID 86102]
17.Enlace a cita original
Llanos L, Moreu R, Peiró AM, Pascual S, Francés R, Such J, Horga JF, Pérez-Mateo M, Zapater P. Causality assessment of liver injury after chronic oral amiodarone intake. Pharmacoepidemiol Drug Saf 2009;18:291-300. [Ref.ID 85624]
19.Tiene citas relacionadas Cita con resumen
Smith G. Happiness networks. What about social politics?. BMJ 2009;338:253. [Ref.ID 85151]
20.Tiene citas relacionadas Cita con resumen
Mellon JA. Happiness networks. Know your frieds. BMJ 2009;338:252-3. [Ref.ID 85150]
Seleccionar todas
 
 1 a 20 de 261 siguiente >>